Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000352527

Medchemexpress LLC Biotin-PEG6-Thalidomide | 2144775-48-2 | 98.3% | C37H53N5O12S | 25 MG
SDP

Catalog No. 5000352527
Encompass_Preferred

Biotin-PEG6-Thalidomide is a PEG-based PROTAC linker utilized in the synthesis of PROTACs. These PROTACs contain two distinct ligands connected by a linker: one targets an E3 ubiquitin ligase, and the other targets a specific protein. They leverage the intracellular ubiquitin-proteasome system to selectively degrade target proteins. This product is for research use only.

  • PEG-based PROTAC linker
  • Used in the synthesis of PROTACs
  • Exploits the intracellular ubiquitin-proteasome system
  • Selectively degrades target proteins
  • Targets E3 ligase ligand-linker conjugates
  • Targets Cereblon
  • For research use only

Catalog No. 50-003-52527 Supplier Medchemexpress LLC Supplier No. 25MGHY140942
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Biotin-PEG6-Thalidomide is a PEG-based PROTAC linker utilized in the synthesis of PROTACs. These PROTACs contain two distinct ligands connected by a linker: one targets an E3 ubiquitin ligase, and the other targets a specific protein. They leverage the intracellular ubiquitin-proteasome system to selectively degrade target proteins. This product is for research use only.

  • PEG-based PROTAC linker
  • Used in the synthesis of PROTACs
  • Exploits the intracellular ubiquitin-proteasome system
  • Selectively degrades target proteins
  • Targets E3 ligase ligand-linker conjugates
  • Targets Cereblon
  • For research use only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.